These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29593747)

  • 21. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.
    Valkenburg SA; Quiñones-Parra S; Gras S; Komadina N; McVernon J; Wang Z; Halim H; Iannello P; Cole C; Laurie K; Kelso A; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    Nat Commun; 2013; 4():2663. PubMed ID: 24173108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
    Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
    Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
    Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
    Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope specific T-cell responses against influenza A in a healthy population.
    Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
    Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of lung CD8
    Moriyama M; Takeyama H; Hasegawa H; Ichinohe T
    Vaccine; 2017 Dec; 35(48 Pt B):6620-6626. PubMed ID: 29079103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant.
    Murugappan S; Frijlink HW; Petrovsky N; Hinrichs WL
    Eur J Pharm Sci; 2015 Jan; 66():118-22. PubMed ID: 25459531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.
    Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
    Bodewes R; Geelhoed-Mieras MM; Heldens JG; Glover J; Lambrecht BN; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2009 Nov; 27(49):6833-9. PubMed ID: 19772942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How much of virus-specific CD8 T cell reactivity is detected with a peptide pool when compared to individual peptides?
    Zhang W; Moldovan I; Targoni OS; Subbramanian RA; Lehmann PV
    Viruses; 2012 Oct; 4(11):2636-49. PubMed ID: 23202497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.
    Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J
    PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
    Hagenaars N; Verheul RJ; Mooren I; de Jong PH; Mastrobattista E; Glansbeek HL; Heldens JG; van den Bosch H; Hennink WE; Jiskoot W
    J Control Release; 2009 Dec; 140(2):126-33. PubMed ID: 19712713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.